Skip to main content
UC San Diego secured a 25.7M dollar ARPA-H award to develop 3D bioprinted, patient-specific human livers.
Funding
1 min read

UC San Diego secured a 25.7M dollar ARPA-H award to develop 3D bioprinted, patient-specific human livers.

Originally reported by genengnews.com

UC San Diego secured a 25.7M dollar ARPA-H award to develop 3D bioprinted, patient-specific human livers. This project leverages AI-driven design to solve the vascularization bottleneck, enabling high-resolution blood vessel fabrication in mere seconds. By integrating clinical-grade stem cell technology, the initiative aims to eliminate donor waitlists for 12,000 plus patients annually. This transition to industrial-scale bio-manufacturing marks a systemic shift in regenerative medicine. 🧬🏥⚙️ #3DBioprinting #ARPAH #RegenerativeMedicine #AdditiveManufacturing #UCSanDiego

Read Original

How This Connects

6 related events
  1. Same pattern

    CollPlant has launched BioFlex, a ready-to-print rhCollagen kit optimized for high-resolution Digital Light Processing (DLP) 3D bioprinting.

  2. Same pattern

    Auxilium Biotechnologies is partnering with Starlab Space to deploy the AMP-1 bioprinting platform for scalable medical manufacturing in low Earth orbit.

  3. Same pattern

    PrintBio has joined a federal consortium led by WFIRM to receive up to 24.8 million USD from ARPA-H for bioprinting vascularized kidney tissue.

  4. Same pattern

    Carnegie Mellon University secured a 28.5 million dollar ARPA-H award for the LIVE project, developing 3D-printed human liver patches.

  5. Same pattern

    Aspect Biosystems has expanded its partnership with Novo Nordisk to develop bioprinted islet therapies for Type 1 diabetes.

  6. This article

    UC San Diego secured a 25.7M dollar ARPA-H award to develop 3D bioprinted, patient-specific human livers.

  7. Same pattern

    Nanochon secured $4.1M in funding to launch first-in-human trials for its 3D-printed knee implant.